Search

Author/Creator McClure, T.

1. P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET). (23rd June 2022)

Authors:
Palandri, F.; Ross, D. M.; Cochrane, T.; Tate, C.; Lane, S. W.; Larsen, S. R.; Gerds, A. T.; Halpern, A. B.; Shortt, J.; Rossetti, J. M.; Pettit, K. M.; Liang, J.; Mead, A.; Marchetti, M.; Vannucchi, A.; Wilson, A.; Göthert, J. R.; Hanna, M.; Jones, A.; Peppe, J.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
923
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P1051: A PHASE 2 STUDY OF IMG-7289 (BOMEDEMSTAT) IN PATIENTS WITH ADVANCED MYELOFIBROSIS. (23rd June 2022)

Authors:
Gill, H.; Yacoub, A.; Pettit, K.; Bradley, T.; Gerds, A.; Tatarczuch, M.; Shortt, J.; Curtin, N.; Rossetti, J.; Burbury, K.; Mead, A.; Göthert, J.; Koschmieder, S.; Jones, A.; Peppe, J.; Dias, J.; Natsoulis, G.; McClure, T.; Kleppe, M.; Hong, W.-J.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
941
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A phase 1 study of MM-141, a novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3, in relapsed or refractory solid tumors. (December 2016)

Authors:
Isakoff, S.; Bahleda, R.; Saleh, M.; Bordoni, R.; Shields, A.; Dauer, J.; Curley, M.; Baum, J.; McClure, T.; Louis, C.U.; Soria, J.C.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S137
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search